Install

Get the latest updates as we post them — right on your browser

Today's paper. Last Updated: 05/31/2012

Virenque Takes 12th Stage

LUZ ARDIDEN, France -- Richard Virenque claimed France's third consecutive stage win in the Tour de France, and Miguel Indurain extended his overall lead Friday as another top cyclist dropped out.


Claudio Chiappucci of Italy, who has finished in the top six of the Tour since 1990, dropped out before the start of the 12th stage, plagued by a virus.


The stage of 204 kilometers (127 miles) had two major climbs, the famous Tourmalet, 2,115 meters and Luz Ardiden, 1,715 meters.


Virenque pulled far ahead of the pack, and only Marco Pantani of Italy stayed within five minutes of him starting the final climb to Luz Ardiden. Pantani ended up 4 minutes, 34 seconds behind.


Indurain and his Banesto teammates allowed Virenque and Pantani to gain the advantage because they trailed Indurain by more than 15 minutes each entering the day's leg.


Indurain came in more than seven minutes back but ahead of the main pack. His main rival, Tony Rominger of Switzerland, lost more than three minutes to Indurain and is now 7:56 behind the three-time defending champion.


Chiappucci was more than 33 minutes behind in the overall standings when he decided to stop. He barely moved from his hotel room during the off day in Lourdes on Thursday, suffering from what his team manager said was an intestinal virus.




This article has no comments.

Be the first to leave a comment


Discussion
The Moscow Times welcomes your comments and invites you to discuss topics with other readers. Your comment will be posted automatically to enable a live discussion. If you aren't familiar with our comments policy, you can read it here.

If you're a registered user, you can start typing your comment below. If not, take a moment to sign up. and then return to the article.

If your comment doesn't appear, contact us by using our web form.

Comments

Comments via Facebook



print


Comments

This article has no comments.

Be the first to leave a comment





Most Read